Exploring the groundbreaking Phase I clinical trial of bortezomib in pediatric leukemia patients and its impact on cancer treatment.
Discover how bortezomib, a cancer drug, shows promise in treating Niemann-Pick Type C disease by rescuing misfolded NPC1 proteins and reducing cholesterol accumulation.